1. Home
  2. OCS vs UDMY Comparison

OCS vs UDMY Comparison

Compare OCS & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • UDMY
  • Stock Information
  • Founded
  • OCS 2003
  • UDMY 2009
  • Country
  • OCS Switzerland
  • UDMY United States
  • Employees
  • OCS N/A
  • UDMY N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • UDMY Other Consumer Services
  • Sector
  • OCS Health Care
  • UDMY Real Estate
  • Exchange
  • OCS Nasdaq
  • UDMY Nasdaq
  • Market Cap
  • OCS 1.0B
  • UDMY 1.0B
  • IPO Year
  • OCS N/A
  • UDMY 2021
  • Fundamental
  • Price
  • OCS $19.18
  • UDMY $5.15
  • Analyst Decision
  • OCS Strong Buy
  • UDMY Buy
  • Analyst Count
  • OCS 4
  • UDMY 10
  • Target Price
  • OCS $41.00
  • UDMY $9.67
  • AVG Volume (30 Days)
  • OCS 99.7K
  • UDMY 2.2M
  • Earning Date
  • OCS 11-06-2025
  • UDMY 10-29-2025
  • Dividend Yield
  • OCS N/A
  • UDMY N/A
  • EPS Growth
  • OCS N/A
  • UDMY N/A
  • EPS
  • OCS N/A
  • UDMY N/A
  • Revenue
  • OCS $960,668.00
  • UDMY $795,801,000.00
  • Revenue This Year
  • OCS $32.89
  • UDMY $2.52
  • Revenue Next Year
  • OCS $1,043.16
  • UDMY $2.48
  • P/E Ratio
  • OCS N/A
  • UDMY N/A
  • Revenue Growth
  • OCS N/A
  • UDMY 2.53
  • 52 Week Low
  • OCS $14.00
  • UDMY $5.04
  • 52 Week High
  • OCS $23.08
  • UDMY $10.61
  • Technical
  • Relative Strength Index (RSI)
  • OCS 43.14
  • UDMY 25.84
  • Support Level
  • OCS $19.00
  • UDMY $6.80
  • Resistance Level
  • OCS $19.63
  • UDMY $5.86
  • Average True Range (ATR)
  • OCS 0.74
  • UDMY 0.26
  • MACD
  • OCS -0.35
  • UDMY -0.16
  • Stochastic Oscillator
  • OCS 6.04
  • UDMY 7.08

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

Share on Social Networks: